Alkem Lab Financial Statements

Alkem Lab (ALKEM) reported revenue of ₹129.65B in FY2025 with net income of ₹22.15B. Total assets stood at ₹176.91B. Net worth was ₹119.85B (₹11,985 Cr) and free cash flow was ₹16.89B.

Alkem Lab Income Statement

Hover the chart icon for year-over-year change.

FY 2024 – FY 2025

Item	Chart	2024	2025
Revenue		126.68B	129.65B
Cost of Rev. Cost of Revenue		-49.38B	-47.64B
Gross Profit		77.30B	82.00B
SGA Sales, General & Admin		-54.85B	-56.88B
Op. Income Operating Income		19.46B	21.55B
PBT Profit Before Tax		20.23B	25.26B
Net Income		18.11B	22.15B
Dil. Shares Diluted Shares		119.57M	119.57M
Diluted EPS		150.19	181.11

Figures in ₹ — millions (M), billions (B), trillions (T). EPS is earnings per share.

Understanding the Income Statement

The income statement shows Alkem Lab's revenue and expenses over a period. Revenue minus costs gives gross profit; after operating expenses, interest, and taxes, the remainder is net income. Diluted EPS divides net income by all shares that could exist if options and convertibles were exercised.

Alkem Lab Balance Sheet

Hover the chart icon for year-over-year change.

FY 2024 – FY 2025

Item	Chart	2024	2025
Curr. assets Total current assets		104.12B	108.11B
Non-curr. assets Total non-current assets		51.63B	68.80B
Total assets		155.75B	176.91B
Curr. liabilities Total current liabilities		39.95B	39.65B
Non-curr. liab. Total non-current liabilities		8.66B	12.92B
Total liabilities		48.61B	52.57B
Total equity		107.14B	124.34B
Total liab. & eq. Total liabilities & equity		155.75B	176.91B

Figures in ₹ — millions (M), billions (B), trillions (T).

Understanding the Balance Sheet

The balance sheet captures Alkem Lab's financial position at a point in time — what it owns (assets), what it owes (liabilities), and the residual value to shareholders (equity). Total assets always equals total liabilities plus equity.

Alkem Lab Cash Flow Statement

Hover the chart icon for year-over-year change.

FY 2022 – FY 2024

Item	Chart	2022	2024
Net Income		18.44B	20.23B
Operating CF Cash flow Operating Activities		11.11B	19.48B
Capex Investments in PPE		-3.39B	-2.59B
Investing CF Cash flow Investing Activities		-14.35B	-10.09B
Dividend Paid		-4.22B	-5.40B
Financing CF Cash flow Financing Activities		3.80B	-11.45B
Cash (start) Cash at beginning of period		1.74B	2.74B
Cash (end) Cash at end of period		2.32B	663.10M
FCF Free Cash Flow		7.72B	16.89B

Figures in ₹ — millions (M), billions (B), trillions (T).

Understanding Cash Flow

The cash flow statement tracks how Alkem Lab's cash moves through operations, investing, and financing activities. Free cash flow — operating cash minus capital expenditure — shows what is available to return to shareholders.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025